{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:16:51Z","timestamp":1768882611699,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["945151"],"award-info":[{"award-number":["945151"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012357","name":"LifeArc","doi-asserted-by":"publisher","award":["PATHFINDER004"],"award-info":[{"award-number":["PATHFINDER004"]}],"id":[{"id":"10.13039\/100012357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Genetic counselling (GC) for familial colorectal cancer (fCRC) has been previously shown to improve outcomes such as emotional distress and screening adherence. This is the first randomised clinical trial to evaluate the efficacy of GC for fCRC. We included individuals affected or at-risk for fCRC (Lynch syndrome, APC-associated polyposis, other risk-associated pathogenic variants and clinically defined fCRC). Participants were randomised to (1) standard care or (2) standard care and genetic counselling. Measures include empowerment, anxiety, depression, knowledge, emotional distress, perceived social support, risk perception. Eighty-two individuals participated in the study. The average age was 44.81 years old, with 52.4% women. There was a significant effect in the counselling group (42\/82) on post-intervention empowerment scores compared to the control group (40\/82) (\n                    <jats:italic>p\u2009<\/jats:italic>\n                    =\u20090.004,\n                    <jats:italic>d\u2009<\/jats:italic>\n                    =\u20090.71), and similarly for depression (\n                    <jats:italic>p\u2009<\/jats:italic>\n                    =\u20090.025,\n                    <jats:italic>d\u2009<\/jats:italic>\n                    =\u20090.40), anxiety (\n                    <jats:italic>p\u2009<\/jats:italic>\n                    =\u20090.036,\n                    <jats:italic>d\u2009<\/jats:italic>\n                    =\u20090.35) and knowledge (\n                    <jats:italic>p\u2009<\/jats:italic>\n                    =\u20090.016,\n                    <jats:italic>d\u2009<\/jats:italic>\n                    =\u20090.25). Exploratory analysis show that several sociodemographic, affective and cognitive variables are moderating the improvement in empowerment following genetic counselling. Our data show significant improvements for both primary endpoint (empowerment) and secondary endpoints (knowledge, depression, anxiety, emotional distress). Genetic counselling is an effective intervention for fCRC both when the diagnosis is part of a syndrome or clinically defined, and both for affected or at-risk individuals.\n                  <\/jats:p>","DOI":"10.1038\/s41431-025-01921-x","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T17:33:40Z","timestamp":1762536820000},"page":"70-77","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The efficacy of genetic counselling for familial colorectal cancer. A randomised clinical trial"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3038-7547","authenticated-orcid":false,"given":"Andrada","family":"Ciuc\u0103","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Pintea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Moldovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"1921_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10897-005-9014-3","volume":"15","author":"R Resta","year":"2006","unstructured":"Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, Strecker MN, et al. A new definition of genetic counseling: National Society of Genetic Counselors\u2019 task force report. J Genet Counsel. 2006;15:77\u201383.","journal-title":"J Genet Counsel"},{"key":"1921_CR2","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/s0277-9536(01)00133-2","volume":"54","author":"B Meiser","year":"2002","unstructured":"Meiser B, Halliday JL. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med. 2002;54:1463\u201370. https:\/\/doi.org\/10.1016\/s0277-9536(01)00133-2.","journal-title":"Soc Sci Med"},{"key":"1921_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jnci\/djh017","volume":"96","author":"D Braithwaite","year":"2004","unstructured":"Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S. Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2004;96:122\u201333.","journal-title":"J Natl Cancer Inst"},{"key":"1921_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10897-008-9210-z","volume":"18","author":"CM Smerecnik","year":"2009","unstructured":"Smerecnik CM, Mesters I, Verweij E, de Vries NK, de Vries H. A systematic review of the impact of genetic counseling on risk perception accuracy. J Genet Counsel. 2009;18:217.","journal-title":"J Genet Counsel"},{"key":"1921_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10897-017-0067-x","volume":"26","author":"L Madlensky","year":"2017","unstructured":"Madlensky L, Trepanier AM, Cragun D, Lerner B, Shannon KM, Zierhut H. A rapid systematic review of outcomes studies in genetic counseling. J Genet Counsel. 2017;26:361\u201378.","journal-title":"J Genet Counsel"},{"key":"1921_CR6","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1053\/j.gastro.2010.01.054","volume":"138","author":"KW Jasperson","year":"2010","unstructured":"Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology. 2010;138:2044\u201358.","journal-title":"Gastroenterology"},{"key":"1921_CR7","unstructured":"Idos G, Valle L. Lynch Syndrome. Nih.gov. Seattle: University of Washington; 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1211\/."},{"key":"1921_CR8","unstructured":"Jasperson KW, Patel SG, Ahnen DJ. APC-associated polyposis conditions. In GeneReviews. Seattle: University of Washington; 2017."},{"key":"1921_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cgh.2007.09.017","volume":"6","author":"DW Neklason","year":"2008","unstructured":"Neklason DW, Stevens J, Boucher KM, Kerber RA, Matsunami N, Barlow J, et al. American founder mutation for attenuated familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008;6:46\u201352. https:\/\/doi.org\/10.1016\/j.cgh.2007.09.017.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1921_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/nejm200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer \u2014 analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78\u201385. https:\/\/doi.org\/10.1056\/nejm200007133430201.","journal-title":"N Engl J Med"},{"key":"1921_CR11","unstructured":"Cancer Council Australia Colorectal Cancer Guidelines Working Party in 2018. Colorectal cancer risk according to family history - Clinical Guidelines Wiki. 2018. https:\/\/wiki.cancer.org.au\/australia\/Clinical_question:Family_history_and_CRC_risk."},{"key":"1921_CR12","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s10897-017-0082-y","volume":"26","author":"BA Athens","year":"2017","unstructured":"Athens BA, Caldwell SL, Umstead KL, Connors PD, Brenna E, Biesecker BB. A systematic review of randomized controlled trials to assess outcomes of genetic counseling. J Genet Counsel. 2017;26:902\u201333.","journal-title":"J Genet Counsel"},{"key":"1921_CR13","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1200\/JCO.2005.07.102","volume":"23","author":"ER Gritz","year":"2005","unstructured":"Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG, et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2005;23:1902\u201310. https:\/\/doi.org\/10.1200\/JCO.2005.07.102.","journal-title":"J Clin Oncol"},{"key":"1921_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/jmg.38.11.787","volume":"38","author":"K Aktan-Collan","year":"2001","unstructured":"Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, K\u00e4\u00e4ri\u00e4inen H. Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet. 2001;38:787\u201392. https:\/\/doi.org\/10.1136\/jmg.38.11.787.","journal-title":"J Med Genet"},{"key":"1921_CR15","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/jmg.2007.051581","volume":"44","author":"K Aktan-Collan","year":"2007","unstructured":"Aktan-Collan K, Haukkala A, Pylv\u00e4n\u00e4inen K, J\u00e4rvinen HJ, Aaltonen LA, Peltom\u00e4ki P, et al. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. J Med Genet. 2007;44:732\u20138. https:\/\/doi.org\/10.1136\/jmg.2007.051581.","journal-title":"J Med Genet"},{"key":"1921_CR16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10689-013-9628-9","volume":"12","author":"K Aktan-Collan","year":"2013","unstructured":"Aktan-Collan K, K\u00e4\u00e4ri\u00e4inen H, J\u00e4rvinen H, Peltom\u00e4ki P, Pylv\u00e4n\u00e4inen K, Mecklin JP, et al. Psychosocial consequences of predictive genetic testing for lynch syndrome and associations to surveillance behaviour in a 7-year follow-up study. Fam Cancer. 2013;12:639\u201346. https:\/\/doi.org\/10.1007\/s10689-013-9628-9.","journal-title":"Fam Cancer"},{"key":"1921_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10897-007-9111-6","volume":"16","author":"NA Kasparian","year":"2007","unstructured":"Kasparian NA, Wakefield CE, Meiser B. Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales. J Genet Counsel. 2007;16:693\u2013712. https:\/\/doi.org\/10.1007\/s10897-007-9111-6.","journal-title":"J Genet Counsel"},{"key":"1921_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1399-0004.2011.01636.x","volume":"79","author":"M McAllister","year":"2011","unstructured":"McAllister M, Wood A, Dunn G, Shiloh S, Todd C. The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services. Clin Genet. 2011;79:413\u201324. https:\/\/doi.org\/10.1111\/j.1399-0004.2011.01636.x.","journal-title":"Clin Genet"},{"key":"1921_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"1921_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00006842-197905000-00004","volume":"41","author":"M Horowitz","year":"1979","unstructured":"Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med. 1979;41:209\u201318.","journal-title":"Psychosom Med"},{"key":"1921_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1207\/s15327752jpa5201_2","volume":"52","author":"GD Zimet","year":"1988","unstructured":"Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Personal Assess. 1988;52:30\u201341.","journal-title":"J Personal Assess"},{"key":"1921_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/cge.13646","volume":"97","author":"J Yuen","year":"2019","unstructured":"Yuen J, Lee SY, Courtney E, Lim J, Soh H, Li ST, et al. Evaluating empowerment in genetic counseling using patient-reported outcomes. Clin Genet. 2019;97:246\u201356. https:\/\/doi.org\/10.1111\/cge.13646.","journal-title":"Clin Genet"},{"key":"1921_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41431-020-0629-5","volume":"28","author":"JS Voorwinden","year":"2020","unstructured":"Voorwinden JS, Plantinga M, Ausems M, Knoers N, Velthuizen M, Birnie E, et al. Cognitive and affective outcomes of genetic counselling in the Netherlands at group and individual level: a personalized approach seems necessary. Eur J Hum Genet. 2020;28:1187\u201395. https:\/\/doi.org\/10.1038\/s41431-020-0629-5.","journal-title":"Eur J Hum Genet"},{"key":"1921_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1399-0004.2008.01089.x","volume":"74","author":"M Keller","year":"2008","unstructured":"Keller M, Jost R, Haunstetter C, Sattel H, Schroeter C, Bertsch U, et al. Psychosocial outcome following genetic risk counselling for familial colorectal cancer. A comparison of affected patients and family members. Clin Genet. 2008;74:414\u201324. https:\/\/doi.org\/10.1111\/j.1399-0004.2008.01089.x.","journal-title":"Clin Genet"},{"key":"1921_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/GIM.0b013e31804b45db","volume":"9","author":"VR Collins","year":"2007","unstructured":"Collins VR, Meiser B, Ukoumunne OC, Gaff C, John DJS, Halliday JL. The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genet Med. 2007;9:290\u20137. https:\/\/doi.org\/10.1097\/GIM.0b013e31804b45db.","journal-title":"Genet Med"},{"key":"1921_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1399-0004.2010.01622.x","volume":"79","author":"DW Hadley","year":"2011","unstructured":"Hadley DW, Ashida S, Jenkins JF, Calzone KA, Kirsch IR, Koehly LM. Colonoscopy use following mutation detection in Lynch syndrome: exploring a role for cancer screening in adaptation. Clin Genet. 2011;79:321\u20138. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01622.x.","journal-title":"Clin Genet"},{"key":"1921_CR27","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1399-0004.2004.00339.x","volume":"66","author":"B Meiser","year":"2004","unstructured":"Meiser B, Collins V, Warren R, Gaff C, St John DJB, Young MA, et al. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet. 2004;66:502\u201311. https:\/\/doi.org\/10.1111\/j.1399-0004.2004.00339.x.","journal-title":"Clin Genet"},{"key":"1921_CR28","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/pon.1338","volume":"17","author":"S Shiloh","year":"2008","unstructured":"Shiloh S, Koehly L, Jenkins J, Martin J, Hadley D. Monitoring coping style moderates emotional reactions to genetic testing for hereditary nonpolyposis colorectal cancer: a longitudinal study. Psycho Oncol. 2008;17:746\u201355. https:\/\/doi.org\/10.1002\/pon.1338.","journal-title":"Psycho Oncol"},{"key":"1921_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1089\/gtmb.2010.0165","volume":"15","author":"MI Hasenbring","year":"2011","unstructured":"Hasenbring MI, Kreddig N, Deges G, Epplen JT, Kunstmann E, Stemmler S, et al. Psychological impact of genetic counseling for hereditary nonpolyposis colorectal cancer: the role of cancer history, gender, age, and psychological distress. Genet Test Mol Biomark. 2011;15:219\u201325. https:\/\/doi.org\/10.1089\/gtmb.2010.0165.","journal-title":"Genet Test Mol Biomark"},{"key":"1921_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ajmg.a.30839","volume":"137","author":"AH Pieterse","year":"2005","unstructured":"Pieterse AH, Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM. Initial cancer genetic counseling consultation: change in counselees\u2019 cognitions and anxiety, and association with addressing their needs and preferences. Am J Med Genet Part A. 2005;137:27\u201335. https:\/\/doi.org\/10.1002\/ajmg.a.30839.","journal-title":"Am J Med Genet Part A"},{"key":"1921_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1034\/j.1399-0004.2000.580606.x","volume":"58","author":"V Collins","year":"2000","unstructured":"Collins V, Halliday J, Warren R, Williamson R. Cancer worries, risk perceptions and associations with interest in DNA testing and clinic satisfaction in a familial colorectal cancer clinic. Clin Genet. 2000;58:460\u20138. https:\/\/doi.org\/10.1034\/j.1399-0004.2000.580606.x.","journal-title":"Clin Genet"},{"key":"1921_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/gte.2005.9.313","volume":"9","author":"S Loader","year":"2005","unstructured":"Loader S, Shields C, Rowley PT. Impact of genetic counseling and DNA testing on individuals with colorectal cancer with a positive family history: a population-based study. Genet Test. 2005;9:313\u20139. https:\/\/doi.org\/10.1089\/gte.2005.9.313.","journal-title":"Genet Test"},{"key":"1921_CR33","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.pec.2020.06.007","volume":"103","author":"Aljassim","year":"2020","unstructured":"Aljassim, Ostini. Health literacy in rural and urban populations: a systematic review. Patient Educ Counsel. 2020;103:2142\u201354. https:\/\/doi.org\/10.1016\/j.pec.2020.06.007.","journal-title":"Patient Educ Counsel"},{"key":"1921_CR34","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/cncr.33493","volume":"127","author":"S Stangl","year":"2021","unstructured":"Stangl S, Rauch S, Rauh J, Meyer M, M\u00fcller-Nordhorn J, Wildner M, et al. Disparities in accessibility to evidence-based breast cancer care facilities by rural and urban areas in Bavaria, Germany. Cancer. 2021;127:2319\u201332. https:\/\/doi.org\/10.1002\/cncr.33493.","journal-title":"Cancer"},{"key":"1921_CR35","doi-asserted-by":"publisher","first-page":"e1002447","DOI":"10.1371\/journal.pmed.1002447","volume":"14","author":"JJ Kirkham","year":"2017","unstructured":"Kirkham JJ, Davis K, Altman DG, Blazeby JM, Clarke M, Tunis S, et al. Core outcome set-STAndards for development: the COS-STAD recommendations. PLOS Med. 2017;14:e1002447\u2013e1002447. https:\/\/doi.org\/10.1371\/journal.pmed.1002447.","journal-title":"PLOS Med"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01921-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01921-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01921-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:09:51Z","timestamp":1768810191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01921-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1921"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01921-x","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The trial was reviewed and approved by the Institutional Review Board at the Oncology Institute in Cluj-Napoca (123\/15.02.2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}